![]() ![]() ![]() ![]() However, 2017 fiscal year funding for Lyme disease efforts at the National Institutes and Health (NIH) and the CDC, at $39 million, were a tiny fraction of the roughly $3.8 billion budget the two agencies had to work on HIV/AIDS.įor hepatitis C, thought to infect about 3,000 people in 2016, federal support to the two health agencies was $141 million, well below the amount targeted for Lyme disease Tick-borne diseases at record highĪs if to underscore the case the HHS working group laid out for more focus on tick-borne diseases, the CDC today released new data that showed the number of six key tick-borne diseases rose from 48,610 cases in 2016 to 59,349 cases in 2017. The report details how federal funding is lacking, especially given the number of Lyme disease cases compared with other infectious diseases.įor example, in 2016, the 36,429 estimated number of Lyme disease cases-thought to be an 8- to 12-fold underestimate-wasn't much smaller than the 38,782 HIV/AIDS cases reported the same year. Encouraging the development of strategic plans for federal investment in tick-borne diseases. ![]() Developing new rapid and accurate lab tests and antibiotic combinations or therapies for treating acute and chronic illness.Clarifying the mechanism of immune protection for Lyme and other tick-borne diseases.Improving early and accurate diagnosis and treatment.The team's main recommendations include increases in federal resources to meet key research and patient care needs. "The bottom line is: We need to find better ways to care for our patients, and these recommendations will help us do that." Requesting a boost in federal support Working group chair John Aucott, MD, associate professor at Johns Hopkins University School of Medicine and director of its Lyme disease research center, said the report represents the first step in bringing together all relevant stakeholders to develop solutions to a critical and growing public health problem. Brett Giroir, MD, HHS assistant secretary for health, said in the statement, "Patients whose lives are devastated by ongoing effects of tick-borne illnesses are counting on emerging scientific research, evidence-based policy, and the healthcare establishment-including the federal government-to provide solutions." Health officials estimate, however, that only about one tenth of cases are reported to local and state health departments or the CDC.Īs part of its fact-finding, the group sought comments from patients and advocates about the debilitating symptoms of the diseases that often require lengthy treatment and large medical bills that aren't reimbursed by insurers.Īdm. In a press release, HHS said the group recommends a multi-pronged response to address diseases that affects more than 300,000 Americans each year, with cases doubling since 2004. The group's 108-page report appears on the HHS website. The HHS secretary appointed a 14-member working group in December 2017 to address priority areas, including epidemiology, prevention, diagnosis, treatment, access to care, patient outcomes, and a path forward. The Department of Health and Human Services (HHS) report is the result of December 2016 Congressional passage of the 21st Century Cures Act, intended to promote new healthcare innovations targeting an array of public health issues, including tick-borne diseases. A federal advisory group tagged by Congress in 2016 to identify priorities into tick-borne disease research issued its first report today, which comes alongside new data from the US Centers for Disease Control and Prevention (CDC) showing a record number of cases in 2017. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |